Roberto Cusano Selected Research

Transferases

1/2022

Circulating Levels of MiRNAs From 320 Family in Subjects With Lipodystrophy: Disclosing Novel Signatures of the Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Cusano Research Topics

Disease

2	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 04/2023
2	Neoplasms (Cancer) 01/2022 - 09/2006
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 09/2020
2	Dysbiosis 09/2020 - 09/2020
2	Melanoma (Melanoma, Malignant) 09/2006 - 07/2004
1	Liver Diseases (Liver Disease) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Disease Progression 01/2022
1	Autoimmune Hepatitis 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Infections 01/2022
1	Inflammation (Inflammations) 01/2022
1	Lipodystrophy 01/2022
1	Osteopetrosis 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2020
1	Overweight 09/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Multiple Sclerosis 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Bone Fractures (Bone Fracture) 06/2013
1	Levin type Osteogenesis imperfecta 06/2013
1	Neuroblastoma 09/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2006
1	Holoprosencephaly (Arhinencephaly) 03/2003
1	Nervous System Diseases (Neurological Disorders) 03/2003
1	Carcinogenesis 01/2003
1	Wounds and Injuries (Trauma) 01/2003
1	X-Linked Keratosis Follicularis Spinulosa Decalvans 09/2002
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 04/2002
1	MYH9-Related Disorders 02/2002

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2020
2	EnzymesIBA 01/2022 - 04/2002
2	HLA-G Antigens (HLA G)IBA 01/2022 - 10/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 03/2003
1	HLA-A Antigens (HLA-A)IBA 10/2023
1	Interleukin-13IBA 04/2023
1	NucleotidesIBA 04/2023
1	TransferasesIBA 01/2022
1	Thyroid HormonesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Carbidopa (Lodosyn)FDA LinkGeneric 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	alpha-SynucleinIBA 09/2020
1	Neuroprotective AgentsIBA 09/2020
1	B-Cell Activating FactorIBA 01/2017
1	CytokinesIBA 01/2017
1	OsseusIBA 06/2013
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 09/2006
1	Type 1 Melanocortin ReceptorIBA 07/2004
1	Nonsense Codon (Nonsense Mutation)IBA 03/2003
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	OsteopontinIBA 01/2003
1	diamine N-acetyltransferase (spermidine acetyltransferase)IBA 09/2002
1	PutrescineIBA 09/2002
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 04/2002
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 02/2002

Therapy/Procedure

1	Liver Transplantation 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Mediterranean Diet 09/2020
1	Caloric Restriction 09/2020
1	Kidney Transplantation 01/2017